SLP
Simulations Plus Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
simulations plus, inc. (nasdaq: slp) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research and regulatory submissions. we partner with companies to provide a data-driven, ‘strategic modeling methodology’, starting in early discovery, continuing through preclinical/clinical development, and concluding with clinical trials/post approval. with our subsidiaries, cognigen corporation and dilisym services, we offer #1-ranked, easy-to-use software (gastroplus™, admet predictor™, kiwi™, dilisym®, nafldsym®, pkplus™, and more) to bridge data mining, compound library screening with qsar models, pbpk/tk modeling & simulation in animals and humans following administration around the body, and quantitative systems pharmacology approaches. simulations plus technology is licensed to and used by regulatory agencies worldwide. for over 20 years, simulations plus has partnered with our clients to reduce costs and accelerate res
Market Cap: 867 Million
Primary Exchange: NASDAQ
Website: simulations-plus.com
Shares Outstanding: 20 Million
Float: 0
Dividend: 0.23887395021821228 (0.01%)
Beta: 1.2002741386398161
Sector: Professional, Scientific, and Technical Services
Industry: Computer Systems Design Services
Ethical Flags
Longest drawdown: 389 trading days
From: 2018-06-26 To: 2019-05-08
Lowest Point:
Cognigen Launches KIWI Version 4.0
via: Business Wire at 2019-06-11 04:30:00:000
Exciting New Features to its Pharmacometric Communication and Collaboration Platform Cognigen Corporation, a Simulations Plus company (Nasdaq: SLP) and a leading provider of population pharmacokinetic and pharmacodynamic modeling and simulation services, today announced that it ha… read more...
Cognigen Launches KIWI Version 4.0
via: Business Wire at 2019-06-11 04:30:00:000
Exciting New Features to its Pharmacometric Communication and Collaboration Platform Cognigen Corporation, a Simulations Plus company (Nasdaq: SLP) and a leading provider of population pharmacokinetic and pharmacodynamic modeling and simulation services, today announced that it ha… read more...
Cognigen Launches KIWI Version 4.0
via: Business Wire at 2019-06-11 04:30:00:000
Exciting New Features to its Pharmacometric Communication and Collaboration Platform Cognigen Corporation, a Simulations Plus company (Nasdaq: SLP) and a leading provider of population pharmacokinetic and pharmacodynamic modeling and simulation services, today announced that it ha… read more...
Buy Merck For Growth And Its Good Pipeline Of Breakthrough Drugs
via: SeekingAlpha at 2019-06-09 16:11:39:000
Merck ( MRK ) is a buy for the total return investor that also wants some income as the world economy grows. Merck is one of the largest drug companies in the world. MRK is a conservative investment since it is also a defensive company if the market turns down. Merck will be reviewed using T… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|---|---|---|---|---|---|---|---|
| 2019-07-24 | 2019-08-01 | 2019-07-25 | 2019-07-10 | 0.06 | No Change QoQ | |||
| 2019-04-23 | 2019-05-01 | 2019-04-24 | 2019-04-09 | 0.06 | No Change QoQ | |||
| 2019-01-24 | 2019-02-01 | 2019-01-25 | 2019-01-09 | 0.06 | No Change QoQ | |||
| 2018-10-31 | 2018-11-08 | 2018-11-01 | 2018-10-22 | 0.06 | No Change QoQ | |||
| 2018-07-25 | 2018-08-02 | 2018-07-26 | 2018-07-10 | 0.06 | No Change QoQ | |||
| 2018-04-24 | 2018-05-02 | 2018-04-25 | 2018-04-09 | 0.06 | No Change QoQ | |||
| 2018-01-25 | 2018-02-02 | 2018-01-26 | 2018-01-16 | 0.06 | No Change QoQ | |||
| 2017-11-10 | 2017-11-20 | 2017-11-13 | 2017-11-01 | 0.06 | Increase | |||
| 2017-07-26 | 2017-08-04 | 2017-07-28 | 2017-07-18 | 0.05 | No Change QoQ | |||
| 2017-05-04 | 2017-05-15 | 2017-05-08 | 2017-04-26 | 0.05 | No Change QoQ | |||
| 2017-01-26 | 2017-02-06 | 2017-01-30 | 2017-01-20 | 0.05 | No Change QoQ | |||
| 2016-11-08 | 2016-11-17 | 2016-11-10 | 2016-10-31 | 0.05 | No Change QoQ | |||
| 2016-08-09 | 2016-08-18 | 2016-08-11 | 2016-08-01 | 0.05 | No Change QoQ | |||
| 2016-04-28 | 2016-05-09 | 2016-05-02 | 2016-04-22 | 0.05 | No Change QoQ | |||
| 2016-01-27 | 2016-02-05 | 2016-01-29 | 2016-01-19 | 0.05 | No Change QoQ | |||
| 2015-11-05 | 2015-11-16 | 2015-11-09 | 2015-10-28 | 0.05 | No Change QoQ | |||
| 2015-07-21 | 2015-07-30 | 2015-07-23 | 2015-07-13 | 0.05 | No Change QoQ | |||
| 2015-05-07 | 2015-05-18 | 2015-05-11 | 2015-04-29 | 0.05 | No Change QoQ | |||
| 2015-01-22 | 2015-02-02 | 2015-01-26 | 2015-01-15 | 0.05 | No Change QoQ | |||
| 2014-11-05 | 2014-11-14 | 2014-11-07 | 2014-10-28 | 0.05 | No Change QoQ | |||
| 2019-10-24 | 2019-11-01 | 2019-10-25 | 2019-10-14 | 0.06 | No Change QoQ | |||
| 2019-10-24 | 2019-11-01 | 2019-10-25 | 2019-10-14 | 0.06 | Cash | |||
| 2020-01-24 | 2020-02-03 | 2020-01-27 | 2020-01-09 | 0.06 | Cash | |||
| 2020-04-23 | 2020-05-01 | 2020-04-24 | 2020-04-09 | 0.06 | Cash | |||
| 2020-07-24 | 2020-08-03 | 2020-07-27 | 2020-07-09 | 0.06 | Cash | |||
| 2020-10-23 | 2020-11-02 | 2020-10-26 | 2020-10-13 | 0.06 | Cash | |||
| 2023-01-27 | 2023-02-06 | 2023-01-30 | 2023-01-04 | 0.06 | Cash | |||
| 2023-04-21 | 2023-05-01 | 2023-04-24 | 2023-04-05 | 0.06 | Cash | |||
| 2023-07-28 | 2023-08-07 | 2023-07-31 | 2023-07-06 | 0.06 | Cash | |||
| 2023-10-27 | 2023-11-06 | 2023-10-30 | 2023-10-25 | 0.06 | Cash | |||
| 2024-01-26 | 2024-02-05 | 2024-01-29 | 2024-01-03 | 0.06 | Cash |
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|